WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Earnings & Revenue

Open Broker Account

TAK past earnings growth

How has TAK's earnings growth performed historically?
Company
-47.37%
Industry
-5.52%
Market
40.77%
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

TAK past revenue growth

How has TAK's revenue growth performed historically?
Company
7.5%
Industry
223.54%
Market
174.68%
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TAK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TAK earnings and revenue history

Current Revenue
$32.7B
Current Earnings
$2.2B
Current Profit Margin
6.7%

TAK Return on Equity

Current Company
5.3%
Current Industry
12.5%
Current Market
-8.3%
TAK's Return on Equity (5.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TAK announces earnings.

TAK Return on Assets

Current Company
2.3%
Current Industry
3.8%
TAK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TAK Return on Capital Employed

Current Company
5.15%
Current Industry
8.1%
TAK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TAK vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TAK$32.30B$8.58B$2.18B+19.65%-3.21%
ZTS$8.01B$3.25B$2.07B+9.34%+18.11%
VTRS$16.73B$4.64B$803.60M+6.98%-16.95%
TEVA$15.14B$191.00M-$1.29B-5.72%N/A
RDY$2.73B$575.00M$300.61M+5.35%+10.90%

TAK earnings dates

Next earnings date
Feb 2, 2023

Takeda Pharmaceutical Co Earnings & Revenue FAQ

What were TAK's earnings last quarter?

On Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q3 2022 earnings per share (EPS) of $0.37, up 183.97% year over year. Total Takeda Pharmaceutical Co earnings for the quarter were $1.15 billion. In the same quarter last year, Takeda Pharmaceutical Co's earnings per share (EPS) was $0.13.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

What was TAK's earnings growth in the past year?

As of Q4 2022, Takeda Pharmaceutical Co's earnings has grown -47.37% year over year. This is 41.86 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of -5.52%. Takeda Pharmaceutical Co's earnings in the past year totalled $2.18 billion.

What is TAK's earnings date?

Takeda Pharmaceutical Co's earnings date is Invalid Date. Add TAK to your watchlist to be reminded of TAK's next earnings announcement.

What was TAK's revenue last quarter?

On Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q3 2022 revenue of $13.67 billion up 81.02% year over year. In the same quarter last year, Takeda Pharmaceutical Co's revenue was $7.55 billion.

What was TAK's revenue growth in the past year?

As of Q4 2022, Takeda Pharmaceutical Co's revenue has grown 7.5% year over year. This is 216.04 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 223.54%. Takeda Pharmaceutical Co's revenue in the past year totalled $32.30 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.